DOES LONG-TERM AGGRAVATION OF PARKINSONS-DISEASE RESULT FROM NONDOPAMINERGIC LESIONS

[1] AGID Y, 1985, DYSKINESIA RES TREAT, V1, P145

[2] BALLARD P, 1983, NEUROLOGY S2, V33, P90

[3] 6-YEAR RESULTS OF TREATMENT WITH LEVODOPA PLUS BENZERAZIDE IN PARKINSONS-DISEASE [J]. NEUROLOGY, 1976, 26 (05) : 399 - 404

[4] BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5

[5] [H-3] SPIPERONE BINDING, DOPAMINE AND HVA CONCENTRATIONS IN PARKINSONS-DISEASE AND SUPRANUCLEAR PALSY [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 99 (2-3) : 167 - 175

[6] ESTEGUY M, 1985, REV NEUROL, V141, P413

[7] GUILLARD A, 1975, NOUV PRESSE MED, V4, P2503

[8] HORNYKIEWICZ O, 1966, PHARMACOL REV, V18, P925

[9] Javoy-Agid F, 1984, Adv Neurol, V40, P189

[10] JAVOYAGID F, 1986, RECENT DEV PARKINSON, P67

[1] AGID Y, 1985, DYSKINESIA RES TREAT, V1, P145

[2] BALLARD P, 1983, NEUROLOGY S2, V33, P90

[3] 6-YEAR RESULTS OF TREATMENT WITH LEVODOPA PLUS BENZERAZIDE IN PARKINSONS-DISEASE [J]. NEUROLOGY, 1976, 26 (05) : 399 - 404

[4] BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5

[5] [H-3] SPIPERONE BINDING, DOPAMINE AND HVA CONCENTRATIONS IN PARKINSONS-DISEASE AND SUPRANUCLEAR PALSY [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 99 (2-3) : 167 - 175

[6] ESTEGUY M, 1985, REV NEUROL, V141, P413

[7] GUILLARD A, 1975, NOUV PRESSE MED, V4, P2503

[8] HORNYKIEWICZ O, 1966, PHARMACOL REV, V18, P925

[9] Javoy-Agid F, 1984, Adv Neurol, V40, P189

[10] JAVOYAGID F, 1986, RECENT DEV PARKINSON, P67